Excess respiratory viral infections and low antibody responses among HIV-exposed, uninfected infants

AIDS

Volumn 31, Issue 5, 2017, Pages 669-679

  Weinberg, Adriana ^a   Mussi Pinhata, Marisa M ^b   Yu, Qilu ^c   Cohen, Rachel A ^c   Almeida, Volia C ^d   Amaral, Fabiana ^b   Pinto, Jorge ^e   Teixeira, Maria L B ^f   Succi, Regina C M ^g   Freimanis, Laura ^c   Read, Jennifer S ^h,i   Siberry, George ^h  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c WESTAT   (United States)

^d FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f Hospital Federal dos Servidores do Estado   (Brazil)

^g FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antibody responses; childhood vaccines; HIV exposed uninfected infants; immunogenicity; respiratory infections; respiratory viruses; tetanus vaccine

Indexed keywords

HUMAN RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; MATERNAL ANTIBODY; STREPTOCOCCUS PNEUMONIAE ANTIBODY; TETANUS ANTIBODY; TETANUS TOXOID; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BIRTH; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PARAINFLUENZA VIRUS 1; HUMAN PARAINFLUENZA VIRUS 2; HUMAN PARAINFLUENZA VIRUS 3; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; INFLUENZA A; MAJOR CLINICAL STUDY; NONHUMAN; PARAINFLUENZA VIRUS INFECTION; PARAMYXOVIRINAE; PLACENTAL TRANSFER; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SEROCONVERSION; STREPTOCOCCUS PNEUMONIAE; VIRAL RESPIRATORY TRACT INFECTION; ANTIBODY PRODUCTION; BLOOD; ENVIRONMENTAL EXPOSURE; MALE; NEWBORN; PREGNANCY; RESPIRATORY TRACT INFECTION; VIRUS INFECTION; YOUNG ADULT;

ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES; YOUNG ADULT;

EID: 85008343666     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001393     Document Type: Article

References (57)

1. Slogrove A, Reikie B, Naidoo S, De Beer C, Ho K, Cotton M, et al. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr 2012; 58:505-508.
2. Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, et al., ZVITAMBO Study Group. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011; 30:45-51.
3. Marinda E, Humphrey JH, Iliff PJ, Mutasa K, Nathoo KJ, Piwoz EG, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007; 26:519-526.
4. Mussi-Pinhata MM, Freimanis L, Yamamoto AY, Korelitz J, Pinto JA, Cruz ML, et al., National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study Group. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: The National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study. Pediatrics 2007; 119:e694-e704.
5. Kourtis AP, Wiener J, Kayira D, Chasela C, Ellington SR, Hyde L, et al. Health outcomes of HIV-exposed uninfected African infants. AIDS 2013; 27:749-759.
6. Kuhn L, Kasonde P, Sinkala M, Kankasa C, Semrau K, Scott N, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?. Clin Infect Dis 2005; 41:1654-1661.
7. Mussi-Pinhata MM, Motta F, Freimanis-Hance L, de Souza R, Szyld E, Succi RC, et al., NISDI Perinatal Study Group. Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants. Int J Infect Dis 2010; 14 (Suppl 3):e176-e182.
8. Kelly MS, Wirth KE, Steenhoff AP, Cunningham CK, Arscott-Mills T, Boiditswe SC, et al. Treatment failures and excess mortality among hiv-exposed, uninfected children with pneumonia. J Pediatric Infect Dis 2015; 4:e117-e126.
9. Slogrove AL, Frigati L, Gray DM. Maternal HIV and paediatric lung health. Paediatr Respir Rev 2016doi: 10.1016/ j.prrv.2016.08.004. PubMed PMID: 27665511.
10. Shapiro RL, Hughes M, Powis K, Ajibola G, Bennet K, Moyo S, et al. Similar mortality with cotrimoxazole vs placebo in HIVexposed uninfected children. Conference on Retroviruses and Opportunistic Infections 2016.
11. Coutsoudis A, Kindra G, Esterhuizen T. Impact of cotrimoxazole prophylaxis on the health of breast-fed, HIV-exposed, HIV-negative infants in a resource-limited setting. AIDS 2011; 25:1797-1799.
12. Epalza C, Goetghebuer T, Hainaut M, Prayez F, Barlow P, Dediste A, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010; 126:e631-e638.
13. Taron-Brocard C, Le Chenadec J, Faye A, Dollfus C, Goetghebuer T, Gajdos V, et al., France REcherche Nord&Sud Sida-HIV Hepatites-Enquete Perinatale Francaise - CO1/CO11 Study Group. Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country. Clin Infect Dis 2014; 59:1332-1345.
14. Adler C, Haelterman E, Barlow P, Marchant A, Levy J, Goetghebuer T. Severe infections in HIV-exposed uninfected infants born in a European country. PLoS One 2015; 10:e0135375.
15. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96:3866-3871.
16. Miles DJ, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guerin (BCG) vaccine in HIV-uninfected infants. Immunology 2010; 129:446-454.
17. Nielsen SD, Jeppesen DL, Kolte L, Clark DR, Sorensen TU, Dreves AM, et al. Impaired progenitor cell function in HIVnegative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001; 98:398-404.
18. Rich KC, Siegel JN, Jennings C, Rydman RJ, Landay AL. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol 1997; 4:358-361.
19. Hygino J, Lima PG, Filho RG, Silva AA, Saramago CS, Andrade RM, et al. Altered immunological reactivity in HIV-1-exposed uninfected neonates. Clin Immunol 2008; 127:340-347.
20. Hygino J, Vieira MM, Guillermo LV, Silva-Filho RG, Saramago C, Lima-Silva AA, et al. Enhanced Th17 phenotype in uninfected neonates born from viremic HIV-1-infected pregnant women. J Clin Immunol 2011; 31:186-194.
21. Mazzola TN, da Silva MT, Abramczuk BM, Moreno YM, Lima SC, Zorzeto TQ, et al. Impaired Bacillus Calmette-Guerin cellular immune response in HIV-exposed, uninfected infants. AIDS 2011; 25:2079-2087.
22. Ota MO, O'Donovan D, Marchant A, Yamuah L, Harding E, Jaffar S, et al. HIV-negative infants born to HIV-1 but not HIV-2-positive mothers fail to develop a Bacillus Calmette-Guerin scar. AIDS 1999; 13:996-998.
23. Van Rie A, Madhi SA, Heera JR, Meddows-Taylor S, Wendelboe AM, Anthony F, et al. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol 2006; 13:246-252.
24. Ono E, Nunes dos Santos AM, de Menezes Succi RC, Machado DM, de Angelis DS, Salomao R, et al. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz J Med Biol Res 2008; 41:700-708.
25. Gesner M, Papaevangelou V, Kim M, Chen SH, Moore T, Krasinski K, et al. Alteration in the proportion of CD4 T lymphocytes in a subgroup of human immunodeficiency virus-exposed-uninfected children. Pediatrics 1994; 93:624-630.
26. Miyamoto M, Pessoa SD, Ono E, Machado DM, Salomao R, Succi RC, et al. Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents. J Trop Pediatr 2010; 56:427-432.
27. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011; 305:576-584.
28. Reikie BA, Naidoo S, Ruck CE, Slogrove AL, de Beer C, la Grange H, et al. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. Clin Vaccine Immunol 2013; 20:33-38.
29. Abramczuk BM, Mazzola TN, Moreno YM, Zorzeto TQ, Quintilio W, Wolf PS, et al. Impaired humoral response to vaccines among HIV-exposed uninfected infants. Clin Vaccine Immunol 2011; 18:1406-1409.
30. Simani OE, Adrian PV, Violari A, Kuwanda L, Otwombe K, Nunes MC, et al. Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine. AIDS 2013; 27:1583-1591.
31. Sanz-Ramos M, Manno D, Kapambwe M, Ndumba I, Musonda KG, Bates M, et al., CIGNIS study team. Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure. Vaccine 2013; 31:2042-2049.
32. Kattan M, Platzker A, Mellins RB, Schluchter MD, Chen XC, Peavy H, et al. Respiratory diseases in the first year of life in children born to HIV-1-infected women. Pediatr Pulmonol 2001; 31:267-276.
33. Andre-Schmutz I, Dal-Cortivo L, Six E, Kaltenbach S, Cocchiarella F, Le Chenadec J, et al. Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudinebased antiretroviral combination. J Infect Dis 2013; 208:235-243.
34. Enomoto L, Anderson PL, Li S, Edelstein CL, Weinberg A. Effect of nucleoside and nucleotide analog reverse transcriptase inhibitors on cell-mediated immune functions. AIDS Res Hum Retroviruses 2011; 27:47-55.
35. Ruffini DD, Madhi SA. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS 2002; 16:105-112.
36. Slogrove AL, Cotton MF, Esser MM. Severe infections in HIVexposed uninfected infants: Clinical evidence of immunodeficiency. J Trop Pediatr 2010; 56:75-81.
37. McNally LM, Jeena PM, Lalloo U, Nyamande K, Gajee K, Sturm AW, et al. Probable mother to infant transmission of Pneumocystis jiroveci from an HIV-infected woman to her HIV-uninfected infant. AIDS 2005; 19:1548-1549.
38. Read JS, Duarte G, Hance LF, Pinto J, Gouvea MI, Cohen RA, et al., NISDI Perinatal Study Group. The NICHD International Site Development Initiative perinatal cohorts (2002-09). Int J Epidemiol 2012; 41:642-649.
39. Garcia S, Levine OS, Cherian T, Gabastou JM, Andrus J, Working Group M. Pneumococcal disease and vaccination in the Americas: An agenda for accelerated vaccine introduction. Rev Panam Salud Publica 2006; 19:340-348.
40. Quataert S, Martin D, Anderson P, Giebink GS, Henrichsen J, Leinonen M, et al. A multilaboratory evaluation of an enzymelinked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides. Immunol Invest 2001; 30:191-207.
41. Inostroza J, Villanueva S, Mason K, Leiva LE, Sorensen RU. Effects of absorption with pneumococcal type 22F polysaccharide on maternal, cord blood, and infant immunoglobulinG antipneumococcal polysaccharide antibodies. Clin Diagn Lab Immunol 2005; 12:722-726.
42. Izadnegahdar R, Fox MP, Jeena P, Qazi SA, Thea DM. Revisiting pneumonia and exposure status in infants born to HIV-infected mothers. Pediatr Infect Dis J 2014; 33:70-72.
43. Cohen C, Moyes J, Tempia S, Groome M, Walaza S, Pretorius M, et al. Epidemiology of acute lower respiratory tract infection in HIV-exposed uninfected infants. Pediatrics 2016; 137:.
44. Scott S, Moss WJ, Cousens S, Beeler JA, Audet SA, Mugala N, et al. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis 2007; 45:1417-1424.
45. Dangor Z, Kwatra G, Izu A, Adrian P, van Niekerk N, Cutland CL, et al. HIV-1 is associated with lower group B streptococcus capsular and surface-protein IgG antibody levels and reduced transplacental antibody transfer in pregnant women. J Infect Dis 2015; 212:453-462.
46. Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 1993; 329:1524-1530.
47. Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014; 371:918-931.
48. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359:1555-1564.
49. Smolen KK, Cai B, Gelinas L, Fortuno ES 3rd, Larsen M, Speert DP, et al. Single-cell analysis of innate cytokine responses to pattern recognition receptor stimulation in children across four continents. J Immunol 2014; 193:3003-3012.
50. Lalor MK, Floyd S, Gorak-Stolinska P, Ben-Smith A, Weir RE, Smith SG, et al. BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis 2011; 204:1075-1085.
51. Gomez de Aguero M, Ganal-Vonarburg SC, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. The maternal microbiota drives early postnatal innate immune development. Science 2016; 351:1296-1302.
52. Chattha KS, Vlasova AN, Kandasamy S, Esseili MA, Siegismund C, Rajashekara G, Saif LJ. Probiotics and colostrum/milk differentially affect neonatal humoral immune responses to oral rotavirus vaccine. Vaccine 2013; 31:1916-1923.
53. Turfkruyer M, Verhasselt V. Breast milk and its impact on maturation of the neonatal immune system. Curr Opin Infect Dis 2015; 28:199-206.
54. Kakkar F, Lamarre V, Ducruet T, Boucher M, Valois S, Soudeyns H, Lapointe N. Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: Protective mechanism or immunodeficiency. BMC Infect Dis 2014; 14:236.
55. Kidzeru EB, Hesseling AC, Passmore JA, Myer L, Gamieldien H, Tchakoute CT, et al. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIVuninfected infants. AIDS 2014; 28:1421-1430.
56. von Mollendorf C, von Gottberg A, Tempia S, Meiring S, de Gouveia L, Quan V, et al., Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013. Clin Infect Dis 2015; 60:1346-1356.
57. Zash R, Leidner J, Souda S, Binda K, Ribaudo HJ, Moyo S, et al. HIV-exposed children account for more than half of 24-month mortality in Botswana. Conference on Retroviruses and Opportunistic Infections; 2016; Boston, MA.